Killer antibodies in fungal infections

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 334-343

  Conti, S ^a   Magliani, W ^a   Fisicaro, P ^a   Dieci, E ^a   Arseni, S ^a   Salati, A ^a   Polonelli, L ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELL FUNCTION; CELLULAR IMMUNITY; CRYPTOCOCCUS NEOFORMANS; KILLER CELL; MYCOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW;

EID: 0032077848     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80757-8     Document Type: Article

References (82)

1. Aliouat, E.M., Cailliez, J.C., Séguy, N., Dei-Cas, E., Polonelli, L., Gerloni, M., Conti, S. & Camus, D. (1993), Inhibitory effect of a yeast killer toxin to the in vitro Pneumocystis carinii attachment. Serodiagn. Immunother. Infect. Dis., 5, 102-106.
2. Ashman, R.B. & Papadimitriou, J.M. (1995), Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev., 59, 646-672.
3. Barbas III, C.F., Kang, A.S., Lerner, R.A. & Benkovic, S.J. (1991), Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA, 88, 7978-7982.
4. Bodey, G.P. (1966), Fungal infections complicating acute leukemia. J. Chronic Dis., 19, 667-687.
5. Burton, D.R. & Barbas III, C.F. (1994), Human antibodies from combinatorial libraries. Adv. Immunol., 57, 189-280.
6. Bussey, H., Steinmetz O. & Saville, D. (1984), Protein secretion in yeast: two chromosomal mutants that oversecrete killer toxin in Saccharomyces cerevisiae. Curr. Genet., 7, 449-456.
7. Cailliez, J.C., Gerloni, M., Morace, G., Conti, S., Cantelli, C. & Polonelli, L. (1992a), Ultrastructural immunodetection of a Pichia anomala killer toxin, a preliminary study. Biol. Cell, 75, 19-23.
8. Cailliez, J.C., Poulain, D., Mackenzie, D.W.R. & Polonelli, L. (1992b), Cytological immunodetection of yeast glycoprotein secretion. Eur. J. Epidemiol., 8, 452-459.
9. Cailliez, J.C., Cantelli, C., Séguy, N., Conti, S., Gerloni, M., Morace, G. & Polonelli, L. (1994), Killer toxin secretion through the cell wall of the yeast Pichia anomala. Mycopathologia, 126, 173-177.
10. Casadevall, A. (1995), Antibody immunity and invasive fungal infections. Infect. Immun., 63, 4211-4218.
11. Casanova, M, Martinez, J.P. & Chaffin, W. (1990), FAb fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans. Infect. Immun., 58, 3810-3812.
12. Cassone, A., Boccanera, M., Adriani, D., Santoni, G. & De Bernardis, F. (1995), Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun., 63, 2619-2624.
13. Cassone, A., Conti, S., De Bernardis, F. & Polonelli L. (1997), Antibodies, killer toxins and antifungal immunoprotection, a lesson from nature? Immunol. Today, 18, 164-169.
14. Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. (1991), Making antibody fragments using phage display libraries. Nature, 352, 624-628.
15. Coffman, R.L., Lebman, D.A. & Rothman, P. (1993), Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol., 54, 229-270.
16. Conti, S., Cantelli, C., Gerloni, M., Fisicaro, P., Magliani, W., Bertolotti, D., Mozzoni, P., Sullivan, D., Coleman, D. & Polonelli, L. (1996), Killer factor interference in mixed opportunistic yeast cultures. Mycopathologia, 135, 1-8.
17. Conti, S., Fanti, F., Magliani, W., Gerloni, M., Bertolotti, D., Salati, A., Cassone, A. & Polonelli, L. (1998), Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies. J. Infect. Dis., 177, 807-811.
18. Douglas, C.M., Sturley, S.L. & Bostian, K.A. (1988), Role of protein processing, intracellular trafficking and endocytosis in production of and immunity to yeast killer toxin. Eur. J. Epidemiol., 4, 400-408.
19. Dromer, F., Charreire, J., Contrepois, A., Carbon, C. & Yeni, P. (1987a), Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun., 55, 749-752.
20. Dromer, F., Salamero, J, Contrepois, A., Carbon, C. & Yeni, P. (1987b), Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect. Immun., 55, 742-748.
21. Dromer, F., Perrone, C., Barge, J., Vilde, J.L. & Yeni, P. (1989), Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin. Exp. Immunol., 78, 412-417.
22. Feldmesser, M. & Casadevall, A. (1997), Effect of serum IgG1 against murine pulmonary infection with Cryptococcus neoformans. J. Immunol., 158, 790-799.
23. Fidel, P.L., Jr & Sobel, J.D. (1994), The role of cell-mediated immunity in candidiasis. Trends Microbiol., 2, 202-206.
24. Fisher-Hoch, S.P. & Hutwagner, L. (1995), Opportunistic candidiasis : an epidemic of the 1980s. Clin. Infect. Dis., 21, 897-904.
25. Gerloni, M., Xiong, S. & Zanetti, M. (1997), Immunization with immunoglobulin genes, in "The Antibodies, vol. 4" (M. Zanetti & J.D. Capra) (pp. 73-98). Harwood Academic Publishers, Amsterdam.
26. Goldman, D.L., Lee, S.C. & Casadevall, A. (1995), Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect. Immun., 63, 3448-3453.
27. Han, Y. & Cutler, J.E. (1995), Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714-2719.
28. Jackson, H.C., Séguy, N., Mc Killigin, E., Dei-Cas, E., Polonelli, L. & Cailliez, J.C. (1996), Inhibitory effect of a Pichia anomala killer toxin on the viability of rat-derived Pneumocystis carinii. J. Eukaryot. Microbiol., 43, 29S.
29. Janeway, C.A. & Travers, P. (1996), Immunobiology. The immune system in health and disease (2 ed.). Garland Publishing Inc., New York.
30. Jerne, N.K. (1974), Towards a network theory of the immune system. Ann. Immunol./Inst. Pasteur, 125C, 373-389.
31. Levitz, S.M. & Farrell, T.P. (1990), Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsordns, the culture surface, and cytokines. Infect. Immun., 58, 1201-1209.
32. Magliani, W., Conti, S., De Bernardis, F., Gerloni, M., Bertolotti, D., Mozzoni, P., Cassone, A. & Polonelli, L. (1997a), Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nature Biotechnol., 15, 155-158.
33. Magliani, W., Conti, S., Gerloni, M., Bertolotti, D. & Polonelli, L. (1997b), Yeast killer systems. Clin. Microbiol. Rev., 10, 369-400.
34. Matthews, R.C. & Burnie, J.P. (1992), The role of hsp90 in fungal infection. Immunol. Today, 13, 345-348.
35. Matthews, R.C. & Burnie, J.P. (1996), Antibodies against Candida: potential therapeutics? Trends Microbiol., 4, 354-358.
36. Matthews, R.C., Burnie, J.P., Smith, D., Clark, I., Midgley, J., Conolly, M. & Gazzard, B. (1988), Candida and AIDS: evidence for protective antibody. Lancet, 2, 263-265.
37. McCafferty, J., Griffiths, A.D., Winter, G. & Chiswell, D.J. (1990), Phage antibodies: filamentous phage displaying antibody variable domains. Nature, 348, 552-554.
38. Morace, G., Manzara, S., Dettori, G., Fanti, F., Conti, S., Campani, L., Polonelli, L. & Chezzi, C. (1989), Bio-typing of bacterial isolates using the yeast killer system. Eur. J. Epidemiol., 5, 303-310.
39. Mouraud, S. & Friedman, L. (1961), Pathogenicity of Candida. J. Bacteriol., 81, 550-556.
40. Mouraud, S. & Friedman, L. (1968), Passive immunization of mice against Candida albicans. Sabouraudia, 6, 103-105.
41. Mukherjee, J., Nussbaum, G., Scharff, M.D. & Casadevall, A. (1995), Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell. J. Exp. Med., 181, 405-409.
42. Mukherjee, J., Scharff, M.D. & Casadevall, A. (1992), Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun., 60, 4534-4541.
43. Mukherjee, S., Lee, S.C. & Casadevall, A. (1995), Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun., 63, 573-579.
44. Mukherjee, S., Lee, S.C., Mukherjee, J., Scharff, M.D. & Casadevall, A. (1994), Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun., 62, 1079-1088.
45. Murray, P.D., Swain, S.L. & Kagnoff, M.P. (1985), Regulation of the IgM and IgA anti-dextran B1355S response: synergy between IFNγ, BCGF II, and IL-2. J. Immunol., 135, 4015-4020.
46. Murphy, J.W. (1991), Mechanisms of natural resistance to human pathogenic fungi. Ann. Rev. Microbiol., 45, 509-538.
47. Nussbaum, G., Yuan, R., Casadevall, A. & Scharff, M.D. (1996), Immunoglobulin G3 blocking antibodies to Cryptococcus neoformans. J. Exp. Med., 183, 1905-1909.
48. Nussbaum, G., Cleare, W., Casadevall, A., Scharff, M.D. & Valadon, P. (1997), Epitope localization in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J. Exp. Med., 185, 685-694.
49. Pearsall, N.N., Adams, B.L. & Bunni, R. (1978), Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol., 120, 1176-1180.
50. Pettoello-Mantovani, M., Nocerino, A., Polonelli, L., Morace, G., Conti, S., di Martino, L., De Ritis, G., Iafusco, M. & Guandalini, S. (1995), Hansenula anomala killer toxin induces secretion, and severe acute injury in the rat intestine. Gastroenterol., 109, 1900-1906.
51. Pirofski, L. & Casadevall, A. (1996), Antibody immunity to Cryptococcus neoformans: paradigm for antibody immunity to the fungi? Zentralblatt Bakteriologia, 284, 475-495.
52. Polonelli, L. & Morace, G. (1986a), Reevaluation of the yeast killer phenomenon. J. Clin. Microbiol., 24, 866-869.
53. Polonelli, L., Lorenzini, R., De Bernardis, F. & Morace, G. (1986b), Potential therapeutic effect of yeast killer toxin. Mycopathologia, 96, 103-107.
54. Polonelli, L. & Morace, G. (1987), Production and characterization of yeast killer toxin monoclonal antibodies. J. Clin. Microbiol., 25, 460-462.
55. Polonelli, L. & Morace, G. (1988), Yeast killer toxin-like anti-idiotypic antibodies. J. Clin. Microbiol., 26, 602-604.
56. Polonelli, L., Conti, S., Magliani, W. & Morace, G. (1989a), Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. Mycopathologia, 107, 17-23.
57. Polonelli, L., Manzara, S., Conti, S., Dettori, G., Morace, G. & Chezzi, C. (1989b), Serological study of yeast killer toxins by monoclonal antibodies. Mycopathologia, 108, 211-215.
58. Polonelli, L., Fanti, F., Conti, S., Campani, L., Gerloni, M., Castagnola, M., Morace, G. & Chezzi, C. (1990), Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. J. Immunol. Methods, 132, 205-209.
59. Polonelli, L., Conti, S., Gerloni, M., Magliani, W., Castagnola, M., Morace, G. & Chezzi, C. (1991a), "Antibiobodies", antibiotic-like anti-idiotypic antibodies. J. Med. Vet. Mycol., 29, 235-242.
60. Polonelli, L., Conti, S., Gerloni, M., Magliani, W., Morace, G. & Chezzi, C. (1991b), Interfaces of the yeast killer phenomenon. Crit. Rev. Microbiol., 18, 47-87.
61. Polonelli, L., Lorenzini, R., De Bernardis, F., Gerloni, M., Conti, S., Morace, G., Magliani, W. & Chezzi, C. (1993), Idiotypic vaccination, immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scan. J. Immunol., 37, 105-110.
62. Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Gerloni, M., Morace, G., Magliani, W., Chezzi, C. & Cassone, A. (1994), Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like antiidiotypic antibodies. J. Immunol., 152, 3175-3182.
63. Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Magliani, W., Gerloni, M., Cantelli, C. & Cassone, A. (1996), Human natural yeast killer toxin-like candidacidal antibodies. J. Immunol., 156, 1880-1885.
64. Polonelli, L., Séguy, N., Conti, S., Gerloni, M., Bertolotti, D., Cantelli, C., Magliani, W. & Cailliez, J.C. (1997), Monoclonal yeast killer toxin-like candidacidal antiidiotypic antibodies. Clin. Diagn. Lab. Immunol., 4, 142-146.
65. H2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol., 3, 237-240.
66. Romani, L., Puccetti, P. & Bistoni, F. (1995), Biological role of helper T-cell subsets in candidiasis. Chem. Immunol., 63, 113-137.
67. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F. & Poli, V. (1996), Impaired neutrophil response and CD4+ helper cell development in interleukin-6-deficient mice infected with Candida albicans. J. Exp. Med., 183, 1345-1355.
68. Sanford, J.E., Lupan, D.M., Schlagetter, A.M. & Kozel, T.R. (1990), Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun., 58, 1919-1923.
69. Schlagetter, A.M. & Kozel, T.R. (1990), Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun., 58, 1914-1918.
70. Séguy, N., Cailliez, J.C., Polonelli, L., Dei-Cas, E. & Camus, D. (1996a), Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse. Parasitol. Res., 82, 114-116.
71. Séguy, N., Polonelli, L., Conti, S., Dei-Cas, E., Camus, D. & Cailliez, J.C. (1996b), In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies. J. Eukaryot. Microbiol., 43, 27S.
72. Séguy, N., Cailliez, J.C., Delcourt, P., Conti, S., Camus, D., Dei-Cas, E. & Polonelli, L., (1997), Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii. Mol. Med., 3, 544-552.
73. Starmer, W.T., Ganter, P.F., Aberdeen, V., Lachance, M.-A. & Phaff, H.J. (1987), The ecological role of killer yeasts in natural communities of yeasts. Can. J. Microbiol., 33, 783-796.
74. Tavares, D., Ferreira, P., Vilanova, M., Videira, A. & Arala Chaves, M. (1995), Immunoprotection against systemic candidiasis in mice. Int. Immunol., 7, 785-796.
75. Tipper, D.J. &. Bostian, K.A. (1984), Double-stranded ribonucleic acid killer systems in yeasts. Microbiol. Rev., 48, 125-156.
76. Ward, E.S., Gussow, D., Griffiths, A.D., Jones, P.T. & Winter, G. (1989), Binding activities of a repertoire of single immunglobulin variable domains secreted from Escherichia coli. Nature, 341, 544-546.
77. Warnock, D.W. & Richardson, M.D. (1990), Fungal infections in the compromised patient. John Wiley & Sons, London.
78. Wickner, R.B. (1985), Killer yeasts, in "Current topics in Medical Mycology" (M.R. McGinnis) (pp. 286-312). Springer-Verlag, New York.
79. Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. (1994), Making antibodies by phage display technology. Annu. Rev. Immunol., 12, 433-455.
80. Yamamoto, T., Iratani, T., Hirata, H., Imai, M. & Yamaguchi, H. (1986), Killer toxin from Hansenula mrakii selectively inhibits cell wall synthesis in a sensitive yeast. FEBS Lett., 197, 50-54.
81. Yuan, R.R., Casadevall, A., Oh, J. & Scharff, M.D. (1997), T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA, 94, 2483-2488.
82. Yuan, R.R., Casadevall, A., Spira, G. & Scharff, M.D. (1995), Isotype switching from IgG3 to IgG1 converts a non-protective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol., 154, 1810-1816.